75 related articles for article (PubMed ID: 11511106)
1. Identification of a novel retrovirus long terminal repeat (LTR) that is targeted by p51A (TAp63gamma) and selective dominant-negative activity of p73L (DeltaNp63alpha) toward p53-responsive promoter activities.
Senoo M; Matsumura Y; Habu S
Biochem Biophys Res Commun; 2001 Aug; 286(3):628-34. PubMed ID: 11511106
[TBL] [Abstract][Full Text] [Related]
2. TAp63gamma (p51A) and dNp63alpha (p73L), two major isoforms of the p63 gene, exert opposite effects on the vascular endothelial growth factor (VEGF) gene expression.
Senoo M; Matsumura Y; Habu S
Oncogene; 2002 Apr; 21(16):2455-65. PubMed ID: 11971180
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional dysregulation of the p73L / p63 / p51 / p40 / KET gene in human squamous cell carcinomas: expression of Delta Np73L, a novel dominant-negative isoform, and loss of expression of the potential tumour suppressor p51.
Senoo M; Tsuchiya I; Matsumura Y; Mori T; Saito Y; Kato H; Okamoto T; Habu S
Br J Cancer; 2001 May; 84(9):1235-41. PubMed ID: 11336476
[TBL] [Abstract][Full Text] [Related]
4. p51A (TAp63gamma), a p53 homolog, accumulates in response to DNA damage for cell regulation.
Katoh I; Aisaki KI; Kurata SI; Ikawa S; Ikawa Y
Oncogene; 2000 Jun; 19(27):3126-30. PubMed ID: 10871867
[TBL] [Abstract][Full Text] [Related]
5. Analysis of molecular interactions of the p53-family p51(p63) gene products in a yeast two-hybrid system: homotypic and heterotypic interactions and association with p53-regulatory factors.
Kojima T; Ikawa Y; Katoh I
Biochem Biophys Res Commun; 2001 Mar; 281(5):1170-5. PubMed ID: 11243857
[TBL] [Abstract][Full Text] [Related]
6. Human p53-p51 (p53-related) fusion protein: a potent BAX transactivator.
Ikawa S; Obinata M; Ikawa Y
Jpn J Cancer Res; 1999 Jun; 90(6):596-9. PubMed ID: 10429649
[TBL] [Abstract][Full Text] [Related]
7. A second p53-related protein, p73L, with high homology to p73.
Senoo M; Seki N; Ohira M; Sugano S; Watanabe M; Inuzuka S; Okamoto T; Tachibana M; Tanaka T; Shinkai Y; Kato H
Biochem Biophys Res Commun; 1998 Jul; 248(3):603-7. PubMed ID: 9703973
[TBL] [Abstract][Full Text] [Related]
8. Cloning and functional analysis of human p51, which structurally and functionally resembles p53.
Osada M; Ohba M; Kawahara C; Ishioka C; Kanamaru R; Katoh I; Ikawa Y; Nimura Y; Nakagawara A; Obinata M; Ikawa S
Nat Med; 1998 Jul; 4(7):839-43. PubMed ID: 9662378
[TBL] [Abstract][Full Text] [Related]
9. p53 gene family p51(p63)-encoded, secondary transactivator p51B(TAp63alpha) occurs without forming an immunoprecipitable complex with MDM2, but responds to genotoxic stress by accumulation.
Okada Y; Osada M; Kurata S; Sato S; Aisaki K; Kageyama Y; Kihara K; Ikawa Y; Katoh I
Exp Cell Res; 2002 Jun; 276(2):194-200. PubMed ID: 12027449
[TBL] [Abstract][Full Text] [Related]
10. The emerging p53 gene family.
Kaelin WG
J Natl Cancer Inst; 1999 Apr; 91(7):594-8. PubMed ID: 10203277
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated transfer of p53-related genes induces apoptosis of human cancer cells.
Ishida S; Yamashita T; Nakaya U; Tokino T
Jpn J Cancer Res; 2000 Feb; 91(2):174-80. PubMed ID: 10761704
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of p51A/TAp63gamma, a p53 homolog, in non-small cell lung cancer and breast cancer.
Sunahara M; Shishikura T; Takahashi M; Todo S; Yamamoto N; Kimura H; Kato S; Ishioka C; Ikawa S; Ikawa Y; Nakagawara A
Oncogene; 1999 Jun; 18(25):3761-5. PubMed ID: 10391684
[TBL] [Abstract][Full Text] [Related]
13. Effects of p51/p63 missense mutations on transcriptional activities of p53 downstream gene promoters.
Kato S; Shimada A; Osada M; Ikawa S; Obinata M; Nakagawara A; Kanamaru R; Ishioka C
Cancer Res; 1999 Dec; 59(23):5908-11. PubMed ID: 10606233
[TBL] [Abstract][Full Text] [Related]
14. Failure of viral oncoproteins to target the p53-homologue p51A.
Roth J; Dobbelstein M
J Gen Virol; 1999 Dec; 80 ( Pt 12)():3251-3255. PubMed ID: 10567658
[TBL] [Abstract][Full Text] [Related]
15. p51/p63, a novel p53 homologue, potentiates p53 activity and is a human cancer gene therapy candidate.
Kunisaki R; Ikawa S; Maeda T; Nakazaki Y; Kurita R; Harata M; Shutoh Y; Bai YS; Soda Y; Tanabe T; Dohi T; Kato R; Ikawa Y; Asano S; Tani K
J Gene Med; 2006 Sep; 8(9):1121-30. PubMed ID: 16832836
[TBL] [Abstract][Full Text] [Related]
16. The transcriptional activities of p53 and its homologue p51/p63: similarities and differences.
Shimada A; Kato S; Enjo K; Osada M; Ikawa Y; Kohno K; Obinata M; Kanamaru R; Ikawa S; Ishioka C
Cancer Res; 1999 Jun; 59(12):2781-6. PubMed ID: 10383130
[TBL] [Abstract][Full Text] [Related]
17. p73 expression modulates p63 and Mdm2 protein presence in complex with p53 family-specific DNA target sequence in squamous cell carcinogenesis.
Johnson J; Lagowski J; Lawson S; Liu Y; Kulesz-Martin M
Oncogene; 2008 Apr; 27(19):2780-7. PubMed ID: 18026135
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated transfer of the p53 family genes, p73 and p51/p63 induces cell cycle arrest and apoptosis in colorectal cancer cell lines: potential application to gene therapy of colorectal cancer.
Sasaki Y; Morimoto I; Ishida S; Yamashita T; Imai K; Tokino T
Gene Ther; 2001 Sep; 8(18):1401-8. PubMed ID: 11571580
[TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of the p63/p73L/p51/p40/CUSP/KET gene in human cancer cell lines using intronic primers.
Hagiwara K; McMenamin MG; Miura K; Harris CC
Cancer Res; 1999 Sep; 59(17):4165-9. PubMed ID: 10485447
[TBL] [Abstract][Full Text] [Related]
20. Another p53 Doppelgänger?
Kaelin WG
Science; 1998 Jul; 281(5373):57-8. PubMed ID: 9679018
[No Abstract] [Full Text] [Related]
[Next] [New Search]
